HDMA President and CEO John M. Gray released a statement following the House Energy and Commerce Subcommittee on Health’s markup of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (H.R. 471), sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.)
Physician’s offices and independently owned and operated physician clinics remain the largest customer base for specialty pharmaceutical distributors, at 63 percent of their sales value, according to the 2014 Specialty Pharmaceutical Distribution: Facts, Figures and Trends, published by HDMA’s Center for Healthcare Supply Chain Research. The 2014 edition is sponsored by CuraScript Specialty Distribution, an Express Scripts Company; Genentech, A Member of the Roche Group; AstraZeneca Pharmaceuticals LP; and Pharmacy First.
A new study commissioned by HDMA and conducted by Hamacher Resource Group (HRG), Pharmacist and Patient Conversations at Independent Pharmacy, delves into the dialogue between independent pharmacists and their customers and how those communications impact consumer purchasing decisions. The study is based on electronic and phone surveys of independent pharmacists conducted in 2014 and includes secondary research that supports these most recent findings. The report is the fifth in a series focusing on the opportunities for pharmaceutical distributors and manufacturers to support independent pharmacy.
HDMA President and CEO John M. Gray applauded the reintroduction of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (H.R. 471), introduced today in the House of Representatives. The legislation is sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.)
The Healthcare Distribution Management Association announces the promotion of four staff members.
John Parker
(703) 885-0216
Farah Simonett
(703) 885-0269
